key: cord-0952697-iqic46z8
authors: Belletti, Alessandro; Landoni, Giovanni; Zangrillo, Alberto
title: Pneumothorax and barotrauma in invasively ventilated patients with COVID-19
date: 2021-07-30
journal: Respir Med
DOI: 10.1016/j.rmed.2021.106552
sha: 72a25fba73a07371cd4590d2dbdc7aaca5b8139a
doc_id: 952697
cord_uid: iqic46z8

nan

TEXT 23 Dear Editor, 24 We read with great interest the article by Chopra In their multicenter study, the Authors present incidence, clinical characteristics and outcome of 26 pneumothorax in critically ill patients with coronavirus disease 2019 . They found that 27 pneumothorax rate among invasively ventilated COVID-19 patients is 80/594 (13%), and mortality 28 rate for patients who developed pneumothorax is 50/80 (62%). On the contrary, among 160 29 randomly selected invasively ventilated COVID-19 patients without pneumothorax, mortality was 30 78/160 (49%).

We recently published a systematic review on rate of barotrauma among invasively ventilated 32 COVID-19 patients. 2 Our pooled analysis included data from 13 studies and 1,814 patients, 3-15 and 33 we found that pooled estimate of pneumothorax rate was 10.7% (95% confidence interval [CI] = 34 6.7% to 14.7%), while overall rate of barotrauma event was 16.1% (95% CI = 11.8% to 20.4%). In 35 addition, we found an overall mortality rate for COVID-19 patients who developed barotrauma of 36 61.6% (95% CI = 50.2% to 73.0%), as compared with a mortality of 49.5% (95% CI = 41.1% to 37 58.0%) for COVID-19 patients who did not develop barotrauma. 38 We are pleased to read that our findings are further reinforced by another study, that confirms that 39 pneumothorax rate among mechanically ventilated COVID-19 patients is between 10 and 15%.

Indeed, after including the study by Chopra et al. in an updated meta-analysis, the pooled 41 pneumothorax rate is 11.1% (95% CI = 7.4% to 14.8%) (Figure 1) , while the overall barotrauma 42 rate is 15.4% (95% CI = 11.7% to 19%) (figure 2). Furthermore, the study by Chopra et al. also 43 confirms a mortality rate above 60% for COVID-19 patients with barotrauma (updated pooled 44 estimate = 61.4%; 95% CI = 52.1% to 70.7%) (Figure 3) , as compared with a mortality lower than 45 50% for patients who did not develop barotrauma (updated pooled estimate = 49.5%; 95% CI = 46 42.8% to 52.3%) (Figure 4 ). 

Pneumothorax in critically ill patients with